Mangoceuticals, Inc.
MGRX
$1.73
$0.074.22%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 101.00K | 76.50K | 58.70K | 73.90K | 490.20K |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | 13.20K | 14.00K |
Prepaid Expenses | -- | 83.20K | -- | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 16.90K | 16.90K | 16.90K | 16.90K | 13.30K |
Total Current Assets | 118.00K | 176.70K | 75.60K | 104.10K | 517.60K |
|
|||||
Total Current Assets | 118.00K | 176.70K | 75.60K | 104.10K | 517.60K |
Net Property, Plant & Equipment | 30.00K | 166.10K | 182.10K | 197.80K | 213.10K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 20.69M | 21.53M | 15.23M | 14.61M | 14.61M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -119.80K | -119.80K | -119.80K | -102.90K |
Total Assets | 20.84M | 21.75M | 15.37M | 14.79M | 15.24M |
|
|||||
Total Accounts Payable | 768.00K | 1.18M | 837.50K | 754.00K | 718.70K |
Total Accrued Expenses | 33.00K | -- | -- | 5.60K | 4.70K |
Short-term Debt | 600.00K | -- | 150.00K | 187.50K | 187.50K |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 30.10K | 47.70K | 65.00K | 69.30K | 67.40K |
Total Finance Division Other Current Liabilities | 169.90K | 277.30K | 373.00K | 375.00K | 400.00K |
Total Other Current Liabilities | 169.90K | 277.30K | 373.00K | 375.00K | 400.00K |
Total Current Liabilities | 1.60M | 1.50M | 1.43M | 1.39M | 1.38M |
|
|||||
Total Current Liabilities | 1.60M | 1.50M | 1.43M | 1.39M | 1.38M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | 600.00K | -- | 150.00K | 187.50K | 187.50K |
Capital Leases | -- | -- | -- | 12.20K | 30.10K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 1.60M | 1.50M | 1.43M | 1.40M | 1.41M |
|
|||||
Common Stock & APIC | 50.80M | 45.87M | 35.59M | 31.59M | 30.30M |
Retained Earnings | -31.65M | -25.94M | -20.81M | -17.99M | -15.99M |
Treasury Stock & Other | 97.70K | 322.10K | -835.60K | -217.40K | -486.70K |
Total Common Equity | 19.24M | 20.25M | 13.95M | 13.39M | 13.83M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
|
|||||
Total Common Equity | 19.24M | 20.25M | 13.95M | 13.39M | 13.83M |
Total Preferred Equity | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
Total Minority Interest | -1.20K | -1.20K | -1.10K | -800.00 | -400.00 |
Total Equity | 19.24M | 20.25M | 13.95M | 13.39M | 13.83M |
|